A TREATMENT with the potential to cure leukaemia has been given NHS approval. Obe-cel works by genetically modifying cells to enable the immune system to recognise and attack the cancer. The therapy needs only to be given once in a lifetime. Patients receive two doses intravenously ten days apart. It was developed by Autolus, a…
About admin
